IAIS 2021 3rd Annual Indiana Allergy Meeting
This meeting will provide learners with a range of treatments for severe atopic dermatitis, AERD, billing/coding updates and offering OIT in the medical office.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Indiana Allergy and Immunology Society. The American College of Allergy, Asthma, and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists
Allied health professionals
Learning Objectives
Upon completion of this activity the participants should be able to:
- Discuss a range of treatments available for severe atopic dermatitis and know which treatments may be best for each patient
- Diagnose and treat AERD based on current guidelines
- Optimise billing and coding practices, including telehealth
- Discuss OIT options with food allergy patients
All identified conflicts of interest have been mitigated.
The individuals listed below disclose the following financial relationships:
David E Cohen, MD, MPH
Consultant and Honorarium: Ferndale Laboratories, AsanaMedimetriks [past],Leo, UCB, Novartis, Dermavant, SFJ
FIDE. (FIDE receives industry sponsorship from AbbVie, Almirall, Amgen, Arcutis, Bausch and Lomb, Bristol-Myers Squibb, Celgene Dermavant, Dermira, Janssen, Kyowa Hakko Kirin, LEO, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi Genzyme, Regeneron, Sun Pharma, UCB, Valeant)
Brian Vickery, MD
Research Grant: NIH-NIAID, Food Allergy Research and Education
Other research support: Aimmune therapeutics, DBV technologies, Genentech, Regeneron,
Consultant/advisory board: Aimmune therapeutics, Aravax, AllerGenis, DBC, Food Allergy Research and Education, Reacta Biosciences
Maeve O’Connor, MD
Speaker: GlaskoSmithKline, Takeda, Teva, Astra Zeneca, Sanofi, Pharming, Circassia/Aerocine, Viropharma/Baxalta/Shire, Regeneron, Optinose, GSK, Aimmune, Sanofi
Advisory Board: Strategic Pharmaceutical Strategic Allergy Advisors, Aimmune, Hycor, Precision, Pharming, Teva, ALK, Circassia, Spirometrix, Viropharma/Baxalta/Shire, Thermo Fisher Scientific
The following have no relevant financial relationships to disclose:
David Khan, MD
Joshua Milner, MD
Anne Maitland, MD, PHD
Available Credit
- 5.00 AMA PRA Category 1 Credit™
- 5.00 Attendance